Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Erytech Pharma SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Jul 2016 Reuters Investment Profile 12 $20.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech) is a biopharmaceutical company that ...

18 Jul 2016 GlobalData 44 $300.00

Wright Investors Service Comprehensive Report for Erytech Pharma SA

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

15 Jul 2016 Wright Reports 60 $75.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech) is a biopharmaceutical company that ...

17 Jun 2016 GlobalData 44 $300.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech) is a biopharmaceutical company that ...

17 Mar 2016 GlobalData 53 $300.00

ERYTECH PHARMA: ADR UPDATE - PRIVATE PLACEMENT TO PURSUE GRASPA STRATEGY

The recent €25.4m ($27.7m) private placement provides Erytech with a healthy cash balance, which should allow effective execu...

17 Dec 2015 Edison Investment Research 5 $10.00

ERYTECH PHARMA - PRIVATE PLACEMENT TO PURSUE GRASPA STRATEGY

The recent €25.4m private placement provides Erytech with a healthy cash balance, which should allow effective execution on t...

17 Dec 2015 Edison Investment Research 5 $10.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech Pharma) is a bio-pharmaceutical compa...

02 Dec 2015 GlobalData 48 $300.00

ERYTECH PHARMA S.A. - ON-TRACK FOR GRASPA EU APPROVAL IN 2016

Erytech’s lead product Graspa/Eryasp for leukaemia has been filed in Europe. If approved, Graspa will be commercialised by E...

09 Nov 2015 Edison Investment Research 2 $10.00

ERYTECH PHARMA - EVOLVING ERYASP DEVELOPMENT STRATEGY

Erytech has filed Graspa in Europe for ALL, which could lead to first approval by YE16. In the US, the strategy is evolving, ...

15 Oct 2015 Edison Investment Research 6 $10.00